Jason Mraz Says "YES!" to New York City Residency;

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Jul 16, 2014 at 10:30 AM

Jason Mraz Says "YES!" to New York City Residency; Multi-Grammy(R) Winning Superstar Announces "The Five Boroughs Tour," Set to Hit Venues Across NYC Beginning September 17th in Brooklyn, Followed by the Bronx, Queens, Staten Island, and Manhattan; Dates Conclude With Two Night Stand on the Great Stage of Radio City Music Hall on September 22nd and 23rd

NEW YORK, NY--(Marketwired - Jul 16, 2014) - Atlantic recording artist Jason Mraz has announced a special New York City residency in celebration of his long awaited new album. "YES!" is available now in stores and at all online retailers.

"The Five Boroughs Tour" will see Mraz -- accompanied by his "YES!" collaborators, Raining Jane -- performing shows in Brooklyn, The Bronx, Queens, Staten Island, and Manhattan, a feat previously only accomplished by two other musical artists, David Bowie and NYC's own Beastie Boys. The dates begin September 17^th at Brooklyn Center for Performing Arts at Brooklyn College; September 18^th at The Bronx's Lehman Center for The Performing Arts; Queens College's Colden Auditorium at Kupferberg Center for the Arts on September 19^th ; Staten Island's historic St. George Theatre on September 20^th ; and last, but very definitely not least, a two night stand on the Great Stage at Radio City Music Hall, set for September 22^nd and 23^rd . Tickets for all NYC shows go on-sale on July 21 at 10 AM EDT. More information and ticketing details are available at www.yesnyctour.com .

Mraz announced "The Five Boroughs Tour" earlier today at a special press conference held at the world famous Empire State Building. The San Diego-based singer/songwriter is of course no stranger to the Big Apple, having previously sold out such renowned venues as Madison Square Garden and the aforementioned Radio City Music Hall.

"The Five Boroughs Tour" is part of the first North American leg of Mraz's upcoming "YES!" world tour, slated to visit an array of legendary venues around the planet through 2014 and beyond. Those dates get underway with a three night stand at the GRAMMY® Award-winning singer/songwriter's hometown's historic San Diego Civic Theater, set for August 21^st , 22^nd , and 23^rd . Mraz then continues the tour, choosing to perform in small venues and intimate theaters with several multi-day residencies through November (see attached below).

In other news, Mraz and Raining Jane are set for two high profile TV appearances, including NBC's The Tonight Show Starring Jimmy Fallon on Thursday, July 17^th and NBC's TODAY "Toyota Concert Series" -- broadcast live from New York's Rockefeller Center -- on Friday, July 18^th .

One of the world's hardest working and most beloved artists, Jason Mraz's journey has propelled him from the San Diego coffee house scene to arena, amphitheatres, and stadiums all over the world. A two-time GRAMMY® Award winner and six-time nominee, Mraz made pop history with his record-breaking classic single, "I'm Yours," while also earning platinum and multi-platinum certifications in more than 20 countries. Moreover, the San Diego-based troubadour has proven a truly diverse creative presence. A dedicated surfer, farmer/gardener, filmmaker, and photographer, Mraz is first and foremost a committed global citizen. His impassioned social activism and philanthropic efforts span wide-ranging environmental advocacy and ardent support for LGBT equality. Though it all, Jason Mraz continually confirms and celebrates music's myriad forms and miraculous power, inspiring and delighting his countless fans around the world he calls home.

For more, please see www.jasonmraz.com and www.atlanticrecords.com .

(TOUR ITINERARY BELOW)


JASON MRAZ
"YES!" WORLD TOUR 2014
*on-sale July 18
**on-sale July 19
***on-sale July 21

AUGUST
21, 22, 23*	San Diego, CA	San Diego Civic Theater (8/21 sold out)
25, 26	San Francisco, CA	Davies Symphony Hall
28, 29, 30*	Los Angeles, CA	Pantages Theater (8/28 & 8/29 sold out)
31	Phoenix, AZ	Comerica Theatre

SEPTEMBER
2, 3	Dallas, TX	Winspear Opera House
5	Houston, TX	Cullen Performance Hall (sold out)
6	San Antonio, TX	Tobin Theater
7	Austin, TX	Bass Hall
9*	Atlanta, GA	Fox Theatre
10*	Nashville, TN	Ryman Auditorium
12, 13	Boston, MA	Citi Wang Theatre
14*	Hartford, CT	The Bushnell - Mortensen Hall
17***	Brooklyn, NY	Brooklyn Center for Performing Arts at Brooklyn College
18***	The Bronx, NY	Lehman Center for The Performing Arts
19***	Queens, NY	Colden Auditorium at Kupferberg Center for the Arts
20***	Staten Island, NY	St. George Theatre
22*, 23*	New York, NY	Radio City Music Hall
26	London, UK	Royal Albert Hall
27	Cambridge, UK	Cambridge Corn Exchange (sold out)
28	Manchester, UK	Lowry Theatre
30	Paris, FR	Casino de Paris

OCTOBER
1	Amsterdam, NL	Royal Theatre Carré (sold out)
2	Frankfurt, DE	Alter Oper
3	Hamburg, DE	Laeiszhalle
7*	Montreal, QC	Salle Wilfrid-Pellietier
8, 9	Toronto, ON	Massey Hall
11***	Pittsburgh, PA	Benedum Center
12*	Philadelphia, PA	Academy of Music
13*	Washington, DC	Warner Theatre
15*	Columbus, OH	Palace Theatre
16*	St. Louis, MO	Peabody Opera House
17*	Milwaukee, WI	Riverside Theater
18**	Minneapolis, MN	The State Theatre
21*	Seattle, WA	Benaroya Hall
22*	Spokane, WA	INB PAC
23*	Vancouver, BC	Queen Elizabeth Theater
24*	Portland, OR	Keller Auditorium

NOVEMBER
5*	Indianapolis, IN	Murat Theatre at Old National Centre
6*	Detroit, MI	Fox Theatre
7, 8	Chicago, IL	Chicago Theatre

Contacts: Sheila Richman (National) 212.707.3063 Sheila.Richman@atlanticrecords.com Ashley White (National) 512.435.9260 Ashley.White@atlanticrecords.com Ilana Gold (Online/Tour) 212.707.2749 Ilana.Gold@atlanticrecords.com

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

MWC26 Doha: Bridging Standards for MENA's Future

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Gildan's Crisis: Investors Face Losses Amid Lawsuit

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Innovent's SINTBILO® Hits Primary Endpoint in Study

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Fibocom LTE Modules Test Drive Satellite Connectivity

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

ASTS Faces Class Action; Investors Beware of Pitfalls

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Amplifon Data Breach Spurs Legal Scrutiny for Millions

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

CureGene's Evategrel Aims for Breakthrough in Stroke Care

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...